NEWS COMMENTARY

Eat Just raises $200 million round, bringing total funding to more than $650 million

Published:
March 25, 2021
Services:
CPG More...
Priorities:
“Better-for-You” Transformation More...
Activities:
Investment
by Thomas Hayes
Average importance

Qatar Investment Authority led the round. Eat Just intends to use the latest funding to support production capacity, R&D, and market expansion. The press release included updates on the company's flagship product JUST Egg, a plant-based egg substitute. The product is now available in 20,000 retail locations and 1,000 foodservice locations, having reportedly sold the equivalent of 100 million eggs to date. While Eat Just made headlines in December 2020 when it received the world's first regulatory approval of cell-based meat from Singapore, JUST Egg will be its growth engine for some time. As Eat Just looks to accelerate market expansion, clients should consider opportunities to partner for sales and distribution.

For the original news article, click here .


Further Reading

Hazel Technologies raises $70 million Series C to expand its shelf-life extension technology

News Commentary | April 16, 2021

This Series C round was co‑led by Temesek and Pontifax AgTech, bringing Hazel's total investment to date to $88 million. With this new funding, the company is looking to expand its ethylene inhibitor technology to other geographies like the EU, Southeast Asia, and Africa. The company claims to have ... Not part of subscription

Remedy Health, maker of Nourished 3D-printed personalized vitamin gummies, raises $11 million Series A

News Commentary | May 11, 2021

ADM Ventures and Cibus Fund co‑led the round, which brings Remedy Health's total funding to $14.3 million, with a reported valuation of $71.6 million. The company's revenue has also reportedly grown by 600% over the past year. It intends to use this funding for expansion into children's nutrition ... Not part of subscription

TerViva's $54 million will bring pongamia-derived ingredients to market

News Commentary | May 24, 2021

The funding comes from several industry executives and will be used by TerViva to commercialize its Pongamia‑derived oil and new protein product. In addition to the $54 million, TerViva expects to raise $24 million in equity and debt capital this quarter. TerViva has teamed up with Danone to create ... Not part of subscription